Pharma Journalist -

InVivo Therapeutics Holdings Corporation became recipient of supplemental Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) for a second…
Read More...

Tyber Medical which is a privately held company emphasizing on developing breakthrough medical devices for private label opportunities and facilitating  the science  of bioengineered…
Read More...

Ortho Clinical Diagnostics which is  a global leader of in vitro diagnostics asserted the launch of Ortho's VITROS Immunodiagnostic Products C-peptide Reagent Pack and Calibrators that…
Read More...

Wuxi Biologics and Adagene which is an emerging biotech company discovering and developing innovative antibody therapeutics for its usage globally, declared a collaboration agreement.…
Read More...

Roche declared that its new hematology testing solution, the cobas m 511 integrated hematology analyzer has received 510(k) clearance from the U.S Food and Drug Administration. The…
Read More...

Prokaryotics receives $2.5 million from the National Institute of Allergy and Infectious Diseases as a SBIR. The two-year agreement will fund research by Prokaryotics on the restoration…
Read More...

Spinal Singularity declared that the first patient has been treated with the Connected Catheter which is an innovative, smart catheter system designed for adult males with Chronic…
Read More...

Sweetch which is a mobile-health app that helps prevent and enhance outcomes in diabetes by encouraging long-term behavioral change declared thee outcomes of its clinical trial…
Read More...

According to the newly published research in Molecular and Cellular Proteomics describes a biomarker panel based on patient IgM antibodies that can certainly distinguish between Zika…
Read More...

The American Diabetes Association issues new guidance, "Hemoglobin A1C Targets for Glycemic Control with Pharmacologic Therapy for Nonpregnant Adults with Type 2 Diabetes Mellitus: A…
Read More...